NYSEARCA:LABD Direxion Daily S&P Biotech Bear 3X ETF (LABD) Price, Holdings, & News $7.43 +0.09 (+1.23%) Closing price 09/11/2026 04:10 PM EasternExtended Trading$7.40 -0.03 (-0.40%) As of 09/11/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsNews and TrendsOwnership About Direxion Daily S&P Biotech Bear 3X ETF (NYSEARCA:LABD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get LABD alerts:Sign Up Key Stats Today's Range$6.95▼$7.4450-Day Range$5.90▼$9.3452-Week Range$5.81▼$51.90Volume18.80 million shsAverage Volume8.18 million shsMarket Capitalization$56.17 millionAssets Under Management$101.28 millionDividend Yield8.61%Net Expense Ratio1.07%Aggregate RatingN/A ETF Overview The Direxion Daily S&P Biotech Bear 3X Shares (LABD) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index. LABD was launched on May 28, 2015 and is managed by Direxion. Read More Direxion Daily S&P Biotech Bear 3X ETF ExpensesTypeLABDHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.75%0.55%0.57%0.50%0.53%Other Expenses0.33%0.52%0.53%0.60%0.54%Total Expense1.08%0.76%0.75%0.75%0.73%Fee Waiver-0.01%-0.85%-0.67%-0.78%-0.68%Net Expense1.07%0.58%0.63%0.57%0.60% Receive LABD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Direxion Daily S&P Biotech Bear 3X ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LABD ETF News HeadlinesDirexion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.0752June 23, 2026 | msn.comDirexion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.0853March 26, 2026 | msn.comEarth's biggest energy source: near Grand CanyonThe largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - and much of it sits beneath the desert near the Grand Canyon. A drilling crew just hit the DOE's 2035 targets twelve years early, with costs down 50% in 18 months. Google signed on, Gates invested, and the Pentagon made it a priority. One company has been quietly building this infrastructure for sixty years.September 12 at 1:00 AM | Behind the Markets (Ad)LABD: ETF To Benefit From Downturns In The Biotech IndustryJanuary 26, 2026 | seekingalpha.comDirexion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.2287December 23, 2025 | msn.comDirexion Daily S&P Biotech Bull 3X Shares declares quarterly distribution of $0.1027September 24, 2025 | msn.comSee More Headlines LABD ETF - Frequently Asked Questions How have LABD shares performed this year? Direxion Daily S&P Biotech Bear 3X ETF's stock was trading at $21.06 at the start of the year. Since then, LABD stock has decreased by 64.7% and is now trading at $7.43. When did Direxion Daily S&P Biotech Bear 3X ETF's stock split? Direxion Daily S&P Biotech Bear 3X ETF shares reverse split before market open on Friday, August 28th 2020.The 1-20 reverse split was announced on Monday, July 27th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, August 27th 2020. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. Who are Direxion Daily S&P Biotech Bear 3X ETF's major shareholders? Top institutional investors of Direxion Daily S&P Biotech Bear 3X ETF include Squarepoint Ops LLC (1.47%). How do I buy shares of Direxion Daily S&P Biotech Bear 3X ETF? Shares of LABD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Direxion Daily S&P Biotech Bear 3X ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Direxion Daily S&P Biotech Bear 3X ETF investors own include Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Micron Technology (MU), Direxion Daily S&P Biotech Bull 3X ETF (LABU), NVIDIA (NVDA) and Intel (INTC). Fund Details IssuerDirexion Fund NameDirexion Daily S&P Biotech Bear 3X ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:LABD Inception Date5/28/2015 Fund ManagerPaul Brigandi, Tony Ng WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkS&P Biotechnology Select Industry Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings19 Fund Statistics Assets Under Management$101.28 million Average Daily Volume$18.96 million Discount/Premium-0.01% Leveraged-3.00 Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorRafferty Asset Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume1,065 Put Options272 Call Options793 Short Interest2,210,000 shs Miscellaneous Outstanding Shares7,560,000Beta-2.43 Creation Unit50,000 Creation Fee$250.00 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report Top 10 LABD HoldingsGoldman Finl Sq Trsry Inst 506Holding Weight: 58.54%Dreyfus Govt Cash Man InsHolding Weight: 37.75%Goldman Sachs Fin Gov 465 InstitutHolding Weight: 27.03%Dreyfus Trsry Securities Cash MgmtHolding Weight: 5.68%Citi CollateralHolding Weight: 0.00%S&P Biotechnology Select Industry Index SwapHolding Weight: -0.22%S&P Biotechnology Select Industry Index SwapHolding Weight: -0.69%S&P Biotechnology Select Industry Index SwapHolding Weight: -1.41%S&P Biotechnology Select Industry Index SwapHolding Weight: -6.91%S&P Biotechnology Select Industry Index SwapHolding Weight: -8.72%Full Holdings Details This page (NYSEARCA:LABD) was last updated on 9/12/2026 by MarketBeat.com Staff. From Our PartnersMy ‘one day’ retirement secretTradeSmith's AI research team, backed by a $17 million investment and led by a former NSA codebreaker, built a...TradeSmith | SponsoredThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredThis 38 Dollar Fund Holds Every Major AI Stock and Pays WeeklyThe biggest AI stocks like Nvidia, CrowdStrike, and Palantir now trade for hundreds of dollars a share. One fu...Investors Alley | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored17 Nobel Prize winners… one startling warningOn July 13, 17 Nobel laureates including Bernanke, Krugman, and Stiglitz signed an 88-word letter warning that...Porter & Company | Sponsoredyour job is on the listThe CEO of one of the largest AI labs on earth said it plainly: AI could wipe out half of all entry-level whit...Behind the Markets | SponsoredI called NVDA at $6 - Here's what’s next…Matt McCall called NVDA at 6 dollars - it's since climbed more than 3,100 percent. He's identified 51 stocks t...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bear 3X ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bear 3X ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LABD Stock Alerts